| 000 | 01124nam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | vtls000081601 | ||
| 003 | KUKTEM | ||
| 005 | 20251125095748.0 | ||
| 008 | 140704t2009 nyua f 001 0 eng d | ||
| 020 | _a9781420073171 (hbk.) | ||
| 020 | _a1420073176 (hbk.) | ||
| 039 | 9 |
_a201502031221 _bsaini _y201407041106 _zfauzi |
|
| 040 | _aUMP | ||
| 090 | _aRS200 .P43 2009 | ||
| 245 | 0 | 0 |
_aPharmaceutical preformulation and formulation : _ba practical guide from candidate drug selection to commercial dosage form / _cedited by Mark Gibson |
| 250 | _a2nd ed. | ||
| 260 |
_aNew York : _bInforma Healthcare, _cc2009 |
||
| 300 |
_ax, 541 p. : _bill. ; _c26 cm. |
||
| 490 | 1 |
_aDrugs and the pharmaceutical sciences ; _vv. 199 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 |
_aDrugs _xDosage forms |
|
| 650 | 1 | 2 | _aDrug Compounding |
| 650 | 2 | 2 |
_aBiopharmaceutics _xmethods |
| 700 | 1 |
_aGibson, Mark, _d1957- |
|
| 830 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 199 |
|
| 999 |
_aVIRTUA40 _c74521 _d74527 |
||
| 999 | _aVTLSSORT0080*0200*0201*0400*0900*2450*2500*2600*3000*4900*5040*6500*6501*6502*7000*8300*9992 | ||
| 942 | 0 | 0 | _03 |